tirzepatide compound illegal Eli Lilly sues companies selling alternative versions of its weight loss drug Judge says compounding pharmacies must

Retatrutide Retatrutide (LY3437943) is a triple incretin receptor agonist the first synthetic peptide to simultaneously target GLP-1, GIP, and glucagon receptors (GcgR) in a single molecule

Chris Aiken, MD Director, Psych Partners Editor in Chief, Carlat Psychiatry Report

DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA

Be cautious with salt substitutes like LoSalt or NuSalt, which use potassium chloride instead of sodium - they can dangerously increase potassium levels

Key Takeaways Ozempic (semaglutide) is not a stimulant, but its metabolic benefits, including better blood sugar control and weight loss, can indirectly support improved energy levels in some users